⌘K
Loading ticker…
Precision BioSciences, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Precision BioSciences, Inc. Common Stock (DTIL) has a 3-month relative strength percentile of 60 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 62. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.5%, relative volume 9.68×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
60 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
DTIL is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $3M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $3M |
| VXFVanguard Extended Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DTIL Jan avg: 6.83% median: 0.32% win: 50% σ: 16.78% n: 4 2022-04-12 → 2026-05-29 | DTIL Feb avg: 18.50% median: 6.82% win: 75% σ: 30.59% n: 4 2022-04-12 → 2026-05-29 | DTIL Mar avg: -9.99% median: -19.10% win: 25% σ: 28.72% n: 4 2022-04-12 → 2026-05-29 | DTIL Apr avg: 1.26% median: 11.46% win: 60% σ: 26.49% n: 5 2022-04-12 → 2026-05-29 | DTIL May avg: -4.09% median: -11.91% win: 20% σ: 16.47% n: 5 2022-04-12 → 2026-05-29 | DTIL Jun avg: -17.82% median: -18.81% win: 0% σ: 10.99% n: 4 2022-04-12 → 2026-05-29 (current) | DTIL Jul avg: 3.20% median: 3.91% win: 50% σ: 9.98% n: 4 2022-04-12 → 2026-05-29 | DTIL Aug avg: 1.72% median: 6.34% win: 75% σ: 15.15% n: 4 2022-04-12 → 2026-05-29 | DTIL Sep avg: -12.61% median: -18.45% win: 25% σ: 17.25% n: 4 2022-04-12 → 2026-05-29 | DTIL Oct avg: 10.31% median: 1.61% win: 50% σ: 26.06% n: 4 2022-04-12 → 2026-05-29 | DTIL Nov avg: -8.74% median: -8.49% win: 25% σ: 20.55% n: 4 2022-04-12 → 2026-05-29 | DTIL Dec avg: -20.40% median: -18.33% win: 25% σ: 21.19% n: 4 2022-04-12 → 2026-05-29 |